Search results for "Vaccines"
MKSAP Quiz: Routine visit for a patient with chronic kidney disease
A 45-year-old man is evaluated during a routine visit in September. He has advanced chronic kidney disease due to IgA nephropathy. After his vaccination history is evaluated, what is the most appropriate additional vaccine to administer at this visit?
https://immattersacp.org/weekly/archives/2023/07/18/3.htm
18 Jul 2023
Coadministration of zoster vaccine, COVID-19 booster appears safe, effective
An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023
MKSAP Quiz: Evaluation during a pre-employment examination
A 37-year-old man is evaluated during a pre-employment examination. He is starting a new job as a medical assistant in a primary care office. He has received influenza, COVID-19, and tetanus and diphtheria toxoids vaccines. What is the most appropriate additional vaccine to administer?
https://immattersacp.org/weekly/archives/2023/06/27/3.htm
27 Jun 2023
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
Pandemic enters new phase with end of PHE
COVID-19 isn't gone, but the end of the U.S. public health emergency does mark some significant changes.
https://immattersacp.org/archives/2023/06/pandemic-enters-new-phase-with-end-of-phe.htm
1 Jun 2023
Staying safe on social media
Despite the risks of impersonation or harassment, physicians say participating in social media has considerable professional and personal benefits.
https://immattersacp.org/archives/2023/06/staying-safe-on-social-media.htm
1 Jun 2023
Earn trust, counter misinformation
Physicians are on the front lines of addressing medical misinformation, increasingly figuring out what to address and how.
https://immattersacp.org/archives/2023/06/earn-trust-counter-misinformation.htm
1 Jun 2023
Dabigatran recalled, dense-breast notification required
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/05/dabigatran-recalled-dense-breast-notification-required.htm
1 May 2023
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
https://immattersacp.org/weekly/archives/2023/04/18/2.htm
18 Apr 2023
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023